Profile data is unavailable for this security.
About the company
Kane Biotech Inc. is a Canada-based biotechnology company. The Company is engaged in the research, development and commercialization of technologies and products that prevent and remove microbial biofilms. It has a portfolio of biotechnologies and products, which includes StrixNB, DispersinB, Aledex, bluestem, bluestem, silkstem, goldstem, coactiv+, coactiv+, DermaKB and DermaKB Biofilm. Its Wound Care & Surgical division is focused on the product development of DispersinB for applications in chronic wound care. Its bluestem product line includes water additives, chews, spray and dental wipes. Its other products in development stage include Coactiv+, antimicrobial wound rinse for use in acute and chronic wounds; Coactiv+, antimicrobial surgical hydrogel for use in surgical and acute wounds, and DispersinB Gel for prosthetic joint infection. It also provides Scalp Detoxifier, Shampoo and Shampoo Bars. Its primary markets for its technologies are animal health and human health.
- Revenue in CAD (TTM)165.60k
- Net income in CAD-4.94m
- Incorporated2003
- Employees--
- LocationKane Biotech Inc290-100 Innovation DriveWINNIPEG R3T 6G2CanadaCAN
- Phone+1 (204) 453-1301
- Fax+1 (204) 474-7552
- Websitehttps://kanebiotech.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sirona Biochem Corp | -12.09k | -2.31m | 10.28m | -- | -- | -- | -- | -- | -0.0091 | -0.0091 | -0.00005 | -0.012 | -0.0114 | -- | 0.5203 | -- | -218.11 | -173.09 | -- | -383.49 | -- | -- | -- | -1,405.28 | -- | -8.11 | -- | -- | -94.82 | -51.37 | 28.52 | -- | -- | -- |
Medicure Inc | 21.76m | -1.16m | 11.27m | 25.00 | -- | 0.5497 | 11.13 | 0.518 | -0.1122 | -0.1122 | 2.02 | 1.96 | 0.7499 | 2.52 | 4.11 | 870,400.00 | -4.00 | -13.42 | -5.46 | -18.28 | 64.75 | 61.87 | -5.33 | -27.38 | 1.59 | -- | 0.0227 | -- | -5.94 | -5.71 | -167.55 | -- | -28.82 | -- |
Telo Genomics Corp | 0.00 | -2.97m | 13.05m | 8.00 | -- | 20.82 | -- | -- | -0.0434 | -0.0434 | 0.00 | 0.0084 | 0.00 | -- | -- | 0.00 | -323.36 | -85.03 | -407.98 | -113.86 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -33.66 | -- | 24.41 | -- |
Resverlogix Corp | 0.00 | -14.17m | 13.76m | 18.00 | -- | -- | -- | -- | -0.055 | -0.055 | 0.00 | -0.3683 | 0.00 | -- | -- | 0.00 | -133.25 | -- | -- | -- | -- | -- | -- | -- | 0.0359 | -1.10 | -- | -- | -- | -- | -363.74 | -- | -- | -- |
Numinus Wellness Inc | 20.10m | -24.36m | 14.24m | -- | -- | 3.11 | -- | 0.7084 | -0.0906 | -0.0946 | 0.0752 | 0.0145 | 0.8572 | -- | 11.72 | -- | -103.89 | -77.31 | -129.39 | -84.20 | 30.80 | -- | -121.19 | -323.32 | -- | -13.08 | 0.6044 | -- | 256.95 | -- | 32.59 | -- | -- | -- |
Kane Biotech Inc | 165.60k | -4.94m | 18.46m | -- | -- | -- | -- | 111.46 | -0.0383 | -0.0399 | 0.0013 | -0.089 | 0.0294 | 0.085 | 1.25 | -- | -87.75 | -77.89 | -- | -- | 73.29 | 43.27 | -2,984.41 | -241.85 | 0.2957 | -2.88 | -- | -- | -94.42 | -20.26 | -17.29 | -- | -19.41 | -- |
Briacell Therapeutics Corp | 0.00 | -8.29m | 19.20m | 5.00 | -- | -- | -- | -- | -0.5413 | -0.5413 | 0.00 | -0.5163 | 0.00 | -- | -- | -- | -33.97 | -59.37 | -43.50 | -63.11 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 24.35 | -- | -- | -- |
AEterna Zentaris Inc. | 3.28m | -24.97m | 22.96m | 21.00 | -- | 0.5075 | -- | 6.99 | -20.57 | -20.57 | 2.71 | 14.78 | 0.0572 | 1.52 | 6.36 | -- | -43.46 | -26.24 | -50.57 | -30.34 | 90.69 | 83.68 | -760.32 | -300.31 | 5.93 | -- | 0.0177 | -- | -20.25 | -30.06 | 27.17 | -- | 16.12 | -- |